|
private:delextherapeuticsinc.-2
|
90574
|
May 24th, 2019 12:00AM
|
Epocal Inc.
|
945
|
124.00
|
Open
|
Medical Devices
|
May 23rd, 2019 09:18PM
|
May 23rd, 2019 09:18PM
|
Epocal is a leading manufacturer of a clinical Point Of Care (POC) diagnostic product. The epoc® Blood Analysis System delivers a full menu of results, including pH, partial pressure of oxygen, partial pressure of carbon dioxide, sodium, potassium, ionized calcium, hematocrit, glucose, lactate, creatinine, chloride, and soon BUN and TCO2, in less than a minute. Results are easily integrated into any Laboratory Information System.
Epocal Inc. is an affiliate of Siemens Healthineers since November 2017. In integrating Epocal Inc.’s offerings into its POC Ecosystem™ solution, Siemens Healthineers enables customized testing offerings based on individual facility needs - whether that is handheld testing, benchtop solutions or central lab applications - to help improve process efficiency. The epoc® product line will integrate seamlessly into the Siemens Healthineers POC Ecosystem solution for easy connection from many manufacturers’ point-of-care analyzers to hospital information systems, providing a flexible, long-term solution.
|
Open
|
Point of Care, POC, Blood Test, Blood Analysis
|
Open
|
2060 Walkley Rd
|
Ottawa
|
Ontario
|
CA
|
|
|
DELEX Therapeutics Inc.
|
|
Personal Goods
|
|
private:delextherapeuticsinc.-2
|
90574
|
Mar 15th, 2018 12:00AM
|
Epocal Inc.
|
790
|
131.00
|
Open
|
Medical Devices
|
Mar 14th, 2018 08:26PM
|
Mar 14th, 2018 08:26PM
|
|
Open
|
|
|
|
|
|
|
|
|
DELEX Therapeutics Inc.
|
|
Personal Goods
|
|
private:delextherapeuticsinc.-2
|
90574
|
Feb 17th, 2018 12:00AM
|
Epocal Inc.
|
755
|
145.00
|
Open
|
Medical Devices
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
http://www.alere.com/content/alere/ww/en/careers/jobs-na.html
Epocal was founded in March 2001 and is located in Ottawa, Canada. Epocal's founding entrepreneur, Dr. Imants Lauks, is a recognized world leader in biochips and micro-fabrication of solid-state diagnostic devices. The technology that he developed in the 1980s and 90s, at a previous company he founded, led to the world's first commercial biochips. This biochip technology was the enabling core of the clinical diagnostic products invented by Dr. Lauks. The products comprise a range of acute-care tests run on the world's first handheld general purpose patient-side blood analyzer. This system is now a well established tool of the medical profession available worldwide.
Epocal is implementing an entire blood diagnostic system in FlexCard™ technology, a card format similar to the smart card used in conventional check and telephone cards. Epocal manufactures cards at ultra low cost, leveraging already existing high volume / low cost production technologies for smart cards. The proprietary FlexCard technology, comprising biosensors and integral fluidics on flex circuit modules in a credit card-sized housing, constitutes a disruptive technology advance resulting in products 10 times less expensive to manufacture than existing products. This disruptive advantage enables the company to penetrate markets that are completely inaccessible to current competitors.
The new enterprise point-of-care blood diagnostic system, epoc™ — comprising diagnostic test cards and wireless card readers — is intended to be used in all low volume, distributed testing applications, where high sensitivity and lab quality accuracy is required: in hospitals at the bedside, in physicians' offices and in patients' homes. Epocal's mission is to build a patient-side blood testing business that offers for the first time a much desired high precision point-of-care product that is cost-effective, allowing broad adoption.
|
|
|
|
|
|
|
|
|
|
DELEX Therapeutics Inc.
|
|
Personal Goods
|
|
private:delextherapeuticsinc.-2
|
90574
|
Feb 16th, 2018 12:00AM
|
Epocal Inc.
|
755
|
145.00
|
Open
|
Medical Devices
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
http://www.alere.com/content/alere/ww/en/careers/jobs-na.html
Epocal was founded in March 2001 and is located in Ottawa, Canada. Epocal's founding entrepreneur, Dr. Imants Lauks, is a recognized world leader in biochips and micro-fabrication of solid-state diagnostic devices. The technology that he developed in the 1980s and 90s, at a previous company he founded, led to the world's first commercial biochips. This biochip technology was the enabling core of the clinical diagnostic products invented by Dr. Lauks. The products comprise a range of acute-care tests run on the world's first handheld general purpose patient-side blood analyzer. This system is now a well established tool of the medical profession available worldwide.
Epocal is implementing an entire blood diagnostic system in FlexCard™ technology, a card format similar to the smart card used in conventional check and telephone cards. Epocal manufactures cards at ultra low cost, leveraging already existing high volume / low cost production technologies for smart cards. The proprietary FlexCard technology, comprising biosensors and integral fluidics on flex circuit modules in a credit card-sized housing, constitutes a disruptive technology advance resulting in products 10 times less expensive to manufacture than existing products. This disruptive advantage enables the company to penetrate markets that are completely inaccessible to current competitors.
The new enterprise point-of-care blood diagnostic system, epoc™ — comprising diagnostic test cards and wireless card readers — is intended to be used in all low volume, distributed testing applications, where high sensitivity and lab quality accuracy is required: in hospitals at the bedside, in physicians' offices and in patients' homes. Epocal's mission is to build a patient-side blood testing business that offers for the first time a much desired high precision point-of-care product that is cost-effective, allowing broad adoption.
|
|
|
|
|
|
|
|
|
|
DELEX Therapeutics Inc.
|
|
Personal Goods
|
|
private:delextherapeuticsinc.-2
|
90574
|
Feb 15th, 2018 12:00AM
|
Epocal Inc.
|
755
|
145.00
|
Open
|
Medical Devices
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
http://www.alere.com/content/alere/ww/en/careers/jobs-na.html
Epocal was founded in March 2001 and is located in Ottawa, Canada. Epocal's founding entrepreneur, Dr. Imants Lauks, is a recognized world leader in biochips and micro-fabrication of solid-state diagnostic devices. The technology that he developed in the 1980s and 90s, at a previous company he founded, led to the world's first commercial biochips. This biochip technology was the enabling core of the clinical diagnostic products invented by Dr. Lauks. The products comprise a range of acute-care tests run on the world's first handheld general purpose patient-side blood analyzer. This system is now a well established tool of the medical profession available worldwide.
Epocal is implementing an entire blood diagnostic system in FlexCard™ technology, a card format similar to the smart card used in conventional check and telephone cards. Epocal manufactures cards at ultra low cost, leveraging already existing high volume / low cost production technologies for smart cards. The proprietary FlexCard technology, comprising biosensors and integral fluidics on flex circuit modules in a credit card-sized housing, constitutes a disruptive technology advance resulting in products 10 times less expensive to manufacture than existing products. This disruptive advantage enables the company to penetrate markets that are completely inaccessible to current competitors.
The new enterprise point-of-care blood diagnostic system, epoc™ — comprising diagnostic test cards and wireless card readers — is intended to be used in all low volume, distributed testing applications, where high sensitivity and lab quality accuracy is required: in hospitals at the bedside, in physicians' offices and in patients' homes. Epocal's mission is to build a patient-side blood testing business that offers for the first time a much desired high precision point-of-care product that is cost-effective, allowing broad adoption.
|
|
|
|
|
|
|
|
|
|
DELEX Therapeutics Inc.
|
|
Personal Goods
|
|
private:delextherapeuticsinc.-2
|
90574
|
Feb 14th, 2018 12:00AM
|
Epocal Inc.
|
755
|
145.00
|
Open
|
Medical Devices
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
http://www.alere.com/content/alere/ww/en/careers/jobs-na.html
Epocal was founded in March 2001 and is located in Ottawa, Canada. Epocal's founding entrepreneur, Dr. Imants Lauks, is a recognized world leader in biochips and micro-fabrication of solid-state diagnostic devices. The technology that he developed in the 1980s and 90s, at a previous company he founded, led to the world's first commercial biochips. This biochip technology was the enabling core of the clinical diagnostic products invented by Dr. Lauks. The products comprise a range of acute-care tests run on the world's first handheld general purpose patient-side blood analyzer. This system is now a well established tool of the medical profession available worldwide.
Epocal is implementing an entire blood diagnostic system in FlexCard™ technology, a card format similar to the smart card used in conventional check and telephone cards. Epocal manufactures cards at ultra low cost, leveraging already existing high volume / low cost production technologies for smart cards. The proprietary FlexCard technology, comprising biosensors and integral fluidics on flex circuit modules in a credit card-sized housing, constitutes a disruptive technology advance resulting in products 10 times less expensive to manufacture than existing products. This disruptive advantage enables the company to penetrate markets that are completely inaccessible to current competitors.
The new enterprise point-of-care blood diagnostic system, epoc™ — comprising diagnostic test cards and wireless card readers — is intended to be used in all low volume, distributed testing applications, where high sensitivity and lab quality accuracy is required: in hospitals at the bedside, in physicians' offices and in patients' homes. Epocal's mission is to build a patient-side blood testing business that offers for the first time a much desired high precision point-of-care product that is cost-effective, allowing broad adoption.
|
|
|
|
|
|
|
|
|
|
DELEX Therapeutics Inc.
|
|
Personal Goods
|
|
private:delextherapeuticsinc.-2
|
90574
|
Feb 13th, 2018 12:00AM
|
Epocal Inc.
|
755
|
145.00
|
Open
|
Medical Devices
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
http://www.alere.com/content/alere/ww/en/careers/jobs-na.html
Epocal was founded in March 2001 and is located in Ottawa, Canada. Epocal's founding entrepreneur, Dr. Imants Lauks, is a recognized world leader in biochips and micro-fabrication of solid-state diagnostic devices. The technology that he developed in the 1980s and 90s, at a previous company he founded, led to the world's first commercial biochips. This biochip technology was the enabling core of the clinical diagnostic products invented by Dr. Lauks. The products comprise a range of acute-care tests run on the world's first handheld general purpose patient-side blood analyzer. This system is now a well established tool of the medical profession available worldwide.
Epocal is implementing an entire blood diagnostic system in FlexCard™ technology, a card format similar to the smart card used in conventional check and telephone cards. Epocal manufactures cards at ultra low cost, leveraging already existing high volume / low cost production technologies for smart cards. The proprietary FlexCard technology, comprising biosensors and integral fluidics on flex circuit modules in a credit card-sized housing, constitutes a disruptive technology advance resulting in products 10 times less expensive to manufacture than existing products. This disruptive advantage enables the company to penetrate markets that are completely inaccessible to current competitors.
The new enterprise point-of-care blood diagnostic system, epoc™ — comprising diagnostic test cards and wireless card readers — is intended to be used in all low volume, distributed testing applications, where high sensitivity and lab quality accuracy is required: in hospitals at the bedside, in physicians' offices and in patients' homes. Epocal's mission is to build a patient-side blood testing business that offers for the first time a much desired high precision point-of-care product that is cost-effective, allowing broad adoption.
|
|
|
|
|
|
|
|
|
|
DELEX Therapeutics Inc.
|
|
Personal Goods
|
|
private:delextherapeuticsinc.-2
|
90574
|
Feb 12th, 2018 12:00AM
|
Epocal Inc.
|
755
|
145.00
|
Open
|
Medical Devices
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
http://www.alere.com/content/alere/ww/en/careers/jobs-na.html
Epocal was founded in March 2001 and is located in Ottawa, Canada. Epocal's founding entrepreneur, Dr. Imants Lauks, is a recognized world leader in biochips and micro-fabrication of solid-state diagnostic devices. The technology that he developed in the 1980s and 90s, at a previous company he founded, led to the world's first commercial biochips. This biochip technology was the enabling core of the clinical diagnostic products invented by Dr. Lauks. The products comprise a range of acute-care tests run on the world's first handheld general purpose patient-side blood analyzer. This system is now a well established tool of the medical profession available worldwide.
Epocal is implementing an entire blood diagnostic system in FlexCard™ technology, a card format similar to the smart card used in conventional check and telephone cards. Epocal manufactures cards at ultra low cost, leveraging already existing high volume / low cost production technologies for smart cards. The proprietary FlexCard technology, comprising biosensors and integral fluidics on flex circuit modules in a credit card-sized housing, constitutes a disruptive technology advance resulting in products 10 times less expensive to manufacture than existing products. This disruptive advantage enables the company to penetrate markets that are completely inaccessible to current competitors.
The new enterprise point-of-care blood diagnostic system, epoc™ — comprising diagnostic test cards and wireless card readers — is intended to be used in all low volume, distributed testing applications, where high sensitivity and lab quality accuracy is required: in hospitals at the bedside, in physicians' offices and in patients' homes. Epocal's mission is to build a patient-side blood testing business that offers for the first time a much desired high precision point-of-care product that is cost-effective, allowing broad adoption.
|
|
|
|
|
|
|
|
|
|
DELEX Therapeutics Inc.
|
|
Personal Goods
|
|
private:delextherapeuticsinc.-2
|
90574
|
Feb 11th, 2018 12:00AM
|
Epocal Inc.
|
755
|
145.00
|
Open
|
Medical Devices
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
http://www.alere.com/content/alere/ww/en/careers/jobs-na.html
Epocal was founded in March 2001 and is located in Ottawa, Canada. Epocal's founding entrepreneur, Dr. Imants Lauks, is a recognized world leader in biochips and micro-fabrication of solid-state diagnostic devices. The technology that he developed in the 1980s and 90s, at a previous company he founded, led to the world's first commercial biochips. This biochip technology was the enabling core of the clinical diagnostic products invented by Dr. Lauks. The products comprise a range of acute-care tests run on the world's first handheld general purpose patient-side blood analyzer. This system is now a well established tool of the medical profession available worldwide.
Epocal is implementing an entire blood diagnostic system in FlexCard™ technology, a card format similar to the smart card used in conventional check and telephone cards. Epocal manufactures cards at ultra low cost, leveraging already existing high volume / low cost production technologies for smart cards. The proprietary FlexCard technology, comprising biosensors and integral fluidics on flex circuit modules in a credit card-sized housing, constitutes a disruptive technology advance resulting in products 10 times less expensive to manufacture than existing products. This disruptive advantage enables the company to penetrate markets that are completely inaccessible to current competitors.
The new enterprise point-of-care blood diagnostic system, epoc™ — comprising diagnostic test cards and wireless card readers — is intended to be used in all low volume, distributed testing applications, where high sensitivity and lab quality accuracy is required: in hospitals at the bedside, in physicians' offices and in patients' homes. Epocal's mission is to build a patient-side blood testing business that offers for the first time a much desired high precision point-of-care product that is cost-effective, allowing broad adoption.
|
|
|
|
|
|
|
|
|
|
DELEX Therapeutics Inc.
|
|
Personal Goods
|
|
private:delextherapeuticsinc.-2
|
90574
|
Feb 10th, 2018 12:00AM
|
Epocal Inc.
|
755
|
145.00
|
Open
|
Medical Devices
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
http://www.alere.com/content/alere/ww/en/careers/jobs-na.html
Epocal was founded in March 2001 and is located in Ottawa, Canada. Epocal's founding entrepreneur, Dr. Imants Lauks, is a recognized world leader in biochips and micro-fabrication of solid-state diagnostic devices. The technology that he developed in the 1980s and 90s, at a previous company he founded, led to the world's first commercial biochips. This biochip technology was the enabling core of the clinical diagnostic products invented by Dr. Lauks. The products comprise a range of acute-care tests run on the world's first handheld general purpose patient-side blood analyzer. This system is now a well established tool of the medical profession available worldwide.
Epocal is implementing an entire blood diagnostic system in FlexCard™ technology, a card format similar to the smart card used in conventional check and telephone cards. Epocal manufactures cards at ultra low cost, leveraging already existing high volume / low cost production technologies for smart cards. The proprietary FlexCard technology, comprising biosensors and integral fluidics on flex circuit modules in a credit card-sized housing, constitutes a disruptive technology advance resulting in products 10 times less expensive to manufacture than existing products. This disruptive advantage enables the company to penetrate markets that are completely inaccessible to current competitors.
The new enterprise point-of-care blood diagnostic system, epoc™ — comprising diagnostic test cards and wireless card readers — is intended to be used in all low volume, distributed testing applications, where high sensitivity and lab quality accuracy is required: in hospitals at the bedside, in physicians' offices and in patients' homes. Epocal's mission is to build a patient-side blood testing business that offers for the first time a much desired high precision point-of-care product that is cost-effective, allowing broad adoption.
|
|
|
|
|
|
|
|
|
|
DELEX Therapeutics Inc.
|
|
Personal Goods
|